Surgical pathology of carcinoid heart disease: a study of 139 valves from 75 patients spanning 20 years.

OBJECTIVE To quantitate the pathologic features of carcinoid plaques in a relatively large number of surgical specimens from a single institution. PATIENTS AND METHODS Medical records, operative reports, and surgical specimens were reviewed from all patients with carcinoid heart disease who underwent cardiac valvular surgery at Mayo Clinic, Rochester, Minn, between 1980 and 2000. RESULTS The study group included 75 patients (45 men, 30 women) who ranged in age from 26 to 78 years (mean, 59 years). From these 75 patients, 139 valves had been excised surgically (73 tricuspid, 55 pulmonary, 6 mitral, 5 aortic). Pure regurgitation was the most common dysfunctional state of the tricuspid valve (80% [60/75]), mitral valve (97% [32/33]), and aortic valve (96% [23/24]). The pulmonary valve was more often both stenotic and insufficient (52% [37/71]) than purely regurgitant (30% [21/71]). In all cases, valve dysfunction was attributed to the presence of carcinoid plaques, which caused both thickening and retraction. Thickening was the result of both cellular proliferation and deposition of extracellular matrix. Proliferation of myofibroblasts was observed in all plaques and was mild in 49% (68/139) and moderate or severe in 51% (71/139). Extracellular matrix included collagen (in 99% of the 139 valves), myxoid ground substance (98% [136/139]), and elastin (20% [28/139]). Carcinoid plaques were also involved by neovascularization (94% [131/139]), chronic inflammation (94% [131/139]), and mast cell infiltration (64% [89/139]). Severe thickening was attributable primarily to collagen deposition in tricuspid valves and to myofibroblast proliferation and myxoid matrix in pulmonary valves. CONCLUSIONS Among patients undergoing valvular surgery for carcinoid heart disease, tricuspid and pulmonary valves represented 92% of the excised valves (128/ 139). Although numerous cellular and extracellular features were common to the carcinoid plaques, variability in their relative expression produced appreciable differences in the histologic appearance among the plaques.

[1]  J. Cates,et al.  CARCINOID HEART DISEASE , 1959, British heart journal.

[2]  M. Ra,et al.  Pathology of the heart in the carcinoid syndrome; a comparative study. , 1957 .

[3]  Thorson Ah Studies on carcinoid disease. , 1958 .

[4]  J. Ronan Cardiac sound and ultrasound: echocardiographic and phonocardiographic correlations--Part I. , 1981, Current problems in cardiology.

[5]  A. J. Hauck,et al.  Surgical pathology of the tricuspid valve: a study of 363 cases spanning 25 years. , 1988, Mayo Clinic proceedings.

[6]  K. Oberg,et al.  Surgical treatment of carcinoid heart disease. , 1990, The Journal of thoracic and cardiovascular surgery.

[7]  R. Hall,et al.  Carcinoid heart disease: a clinical pathologic, and therapeutic update. , 1982, Current problems in cardiology.

[8]  J M Feldman,et al.  Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. , 1995, Circulation.

[9]  P. Nihoyannopoulos,et al.  Incidence and evolution of carcinoid syndrome in the heart. , 1997, The Journal of heart valve disease.

[10]  Edwards Wd,et al.  Quantitation of mast cells in 100 normal and 92 diseased human hearts. Implications for interpretation of endomyocardial biopsy specimens. , 1988 .

[11]  R. Lang,et al.  Cardiovascular complications of malignant carcinoid disease. , 1997, American heart journal.

[12]  W. Roberts,et al.  THE CARDIAC DISEASE ASSOCIATED WITH THE CARCINOID SYNDROME (CARCINOID HEART DISEASE). , 1964, The American journal of medicine.

[13]  W. Edwards,et al.  Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. , 1996, Human pathology.

[14]  J. Seward,et al.  Echocardiographic features of carcinoid heart disease. , 1982, The American journal of cardiology.

[15]  A. Tajik,et al.  Valve Disease Associated with Ergot Alkaloid Use: Echocardiographic and Pathologic Correlations , 1992, Annals of Internal Medicine.

[16]  J. Van Dorpe,et al.  Aortic and mitral valve disease induced by ergotamine therapy for migraine: a case report and review of the literature. , 1996, The Journal of heart valve disease.

[17]  A. J. Hauck,et al.  Mitral and aortic valve disease associated with ergotamine therapy for migraine. Report of two cases and review of literature. , 1990, Archives of pathology & laboratory medicine.

[18]  E. Trell,et al.  Carcinoid heart disease. Clinicopathologic findings and follow-up in 11 cases. , 1973, The American journal of medicine.

[19]  W. Edwards,et al.  Surgical pathology of the pulmonary valve: a study of 116 cases spanning 15 years. , 1989, Mayo Clinic proceedings.

[20]  E. Topol,et al.  C-reactive protein: a 'golden marker' for inflammation and coronary artery disease. , 2001, Cleveland Clinic journal of medicine.

[21]  W. Edwards,et al.  Carcinoid disease of the heart. Surgical management of ten patients. , 1992, The Journal of thoracic and cardiovascular surgery.

[22]  W. Roberts,et al.  The carcinoid syndrome: comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease. , 1985, The American journal of medicine.

[23]  W. Roberts,et al.  The carcinoid endocardial plaque; an ultrastructural study. , 1976, Human pathology.

[24]  J. Seward,et al.  Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. , 1993, Circulation.

[25]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[26]  W. Edwards,et al.  Valvular heart disease associated with fenfluramine-phentermine. , 1997, The New England journal of medicine.

[27]  P. Pellikka,et al.  Outcome of cardiac surgery for carcinoid heart disease. , 1995, Journal of the American College of Cardiology.

[28]  Edwards Je Floppy mitral valve syndrome. , 1988 .

[29]  E. Wilander,et al.  Histochemical and immunohistochemical morphology of carcinoid heart disease. , 1991, Pathology, research and practice.